RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Hengze Capital
H

Hengze Capital portfolio

Hengze Capital has 1 portfolio company on record at Recent Funding, with 1 investment in the last 12 months.

Type: Investor.
Portfolio on Recent Funding: 1.
Deals, last 12 months: 1.
Capital in their rounds: $29.97M.
Latest deal: Huasaiboman Medical Cell Biology · Nov 9, 2026.
About this page

Its most recent investment on record is Huasaiboman Medical Cell Biology's $29.97M Series B+ round in November 2026, alongside Hefei Industrial Investment Group Life and Health Company, Hefei Guotou, Guoxin Investment and 3 others. That company is in Health and bio.

What Hengze Capital invests in

How Hengze Capital invests

StageDealsCapital in rounds
Series B+ 1 100%$29.97M

Hengze Capital portfolio companies

CompanyRound with Hengze CapitalTotal raisedLatest raise
HHuasaiboman Medical Cell Biology
Health and bio
Series B+ · $29.97M$29.97MNov 9, 2026
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 1 round on Recent Funding that name Hengze Capital. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Hengze Capital, which is a subset of its real portfolio. API: /api/v1/investors/hengze-capital (get a free API key). More: the most active VC firms and new venture capital funds.